Abbott India Limited
ABBOTINDIA
Rank in Stocks
#3023
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Share Price
$284.73
Market Cap
$6.05B
Change (1 day)
-0.41%
Change (1 year)
-17.16%
Country
IN
Trade Abbott India Limited (ABBOTINDIA)
Category
Healthcare
Revenue for Abbott India Limited (ABBOTINDIA)
Revenue in Jun 2026 TTM: $772.99M
According to Abbott India Limited latest financial reports the company's current revenue (TTM) is $772.99M. In 2024 the company made a revenue of $701.24M an increase over the revenue in the year 2023 that was $650.61M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Abbott India Limited from 2004 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $772.99M | 3.15% |
| 2025 | $749.38M | 6.86% |
| 2024 | $701.24M | 7.78% |
| 2023 | $650.61M | 0.58% |
| 2022 | $646.86M | 9.93% |
| 2021 | $588.44M | 8.35% |
| 2020 | $543.07M | 2.60% |
| 2019 | $529.31M | 4.42% |
| 2018 | $506.91M | 13.64% |
| 2017 | $446.07M | 14.62% |
| 2016 | $389.18M | 8.61% |
| 2015 | $358.32M | 14.89% |
| 2014 | $311.88M | 6.42% |
| 2012 | $293.06M | 7.73% |
| 2011 | $272.03M | 22.82% |
| 2010 | $221.48M | 35.16% |
| 2009 | $163.87M | 22.44% |
| 2008 | $133.84M | -10.95% |
| 2007 | $150.29M | 31.48% |
| 2006 | $114.30M | 17.96% |
| 2005 | $96.90M | 6.51% |
| 2004 | $90.98M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $79.67B | 10,206.12% |
US
|
|
| $99.34B | 12,750.67% |
US
|
|
| $64.39B | 8,229.42% |
US
|
|
| $66.40B | 8,489.97% |
US
|
|
| $77.52B | 9,928.34% |
CH
|
